一例双联抗血小板治疗致皮肤瘀斑的病例分析  

Analysis of A Case of Skin Ecchymosis Caused by Dual Antiplatelet Therapy

作　　者：陈芳超[1] 刘金泳[1] 朱秀梅[1] CHEN Fangchao LIU Jinyong ZHU Xiumei(Department of Pharmacy, Nansha Hospital of Guangzhou First People＇s Hospital, Guangzhou , Guangdong 511457, China)

机构地区：[1]广州市第一人民医院南沙医院药学科,广东广州511457

出　　处：《今日药学》2017年第5期338-340,共3页Pharmacy Today

摘　　要：目的对一例使用双联抗血小板引起皮肤瘀斑的病例进行分析,探讨DAPT的药学监护点,为临床药师深入参与临床提供切入点。方法对患者进行药学监护,查阅文献资料,从药物、患者两方面分析出现不良反应事件的原因。结果患者调整DAPT治疗方案后,患者瘀斑较前消退。结论临床药师开展药学监护,可促进临床安全、合理地使用药物。OBJECTIVE To analysis a case of skin ecchymosis caused by dual antiplatelet therapy （ DAPT）, so as to probe into the pharmaceutical care point of DAPT, and provide breakthrough point for clinieal pharmacists to participate in clinical. METHODS Pharmaceutical care for patients was delivered, and the causes of adverse events from the drug and patients two aspects were analyzed by searching literature. RESULTS Ecchymosis subsided after adjusting the treatment plan. CONCLUSION Clinical pharmacists to carry out pharmaceutical care, can promote clinical safety and rational using of drugs.

关 键 词：双联抗血小板 皮肤瘀斑 案例分析 

分 类 号：R969.3[医药卫生—药理学]